Because cancer cells are more tolerant to genotoxic stress than normal cells, and because we have shown that in the absence of NLRP3, ATM activation attenuation resulted in decreased P-p53 (Ser15), we next addressed whether NLRP3 loss would modulate resistance to Eto-induced apoptosis. The gene discussed is NLRP3; the disease is cancer.